These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10434358)

  • 1. [Physiopathology of diabetes insipidus].
    Ajzenberg C
    Rev Med Interne; 1999 Jul; 20(7):629-30. PubMed ID: 10434358
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular biology of diabetes insipidus.
    Fujiwara TM; Morgan K; Bichet DG
    Annu Rev Med; 1995; 46():331-43. PubMed ID: 7541187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vasopressin type 2 receptor mutations in congenital diabetes insipidus].
    Tsukaguchi H; Matsubara H; Inada M
    Nihon Rinsho; 1998 Jul; 56(7):1848-55. PubMed ID: 9702064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From genes to disease: from vasopressin-V2-receptor and aquaporine-2 to nephrogenic diabetes insipidus].
    Knoers NV; Deen PM
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2402-4. PubMed ID: 11145096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the vasopressin V2 receptor and aquaporin-2 genes in twelve families with congenital nephrogenic diabetes insipidus.
    Vargas-Poussou R; Forestier L; Dautzenberg MD; Niaudet P; Déchaux M; Antignac C
    Adv Exp Med Biol; 1998; 449():387-90. PubMed ID: 10026829
    [No Abstract]   [Full Text] [Related]  

  • 6. Vasopressin type-2 receptor and aquaporin-2 water channel mutants in nephrogenic diabetes insipidus.
    Deen PM; Knoers NV
    Am J Med Sci; 1998 Nov; 316(5):300-9. PubMed ID: 9822112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathogenesis of nephrogenic diabetes insipidus.
    Nguyen MK; Nielsen S; Kurtz I
    Clin Exp Nephrol; 2003 Mar; 7(1):9-17. PubMed ID: 14586738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical importance of the urinary excretion of aquaporin-2.
    Knoers NV; van Os CH
    N Engl J Med; 1995 Jun; 332(23):1575-6. PubMed ID: 7537864
    [No Abstract]   [Full Text] [Related]  

  • 9. Nephrogenic diabetes insipidus.
    Deen PM; Marr N; Kamsteeg EJ; van Balkom BW
    Curr Opin Nephrol Hypertens; 2000 Nov; 9(6):591-5. PubMed ID: 11128419
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nephrogenic diabetes insipidus associated with mutations of vasopressin V2 receptors and aquaporin-2].
    Ishikawa SE
    Nihon Rinsho; 2002 Feb; 60(2):350-5. PubMed ID: 11857925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analyses of the vasopressin type 2 receptor and aquaporin-2 genes in Brazilian kindreds with nephrogenic diabetes insipidus.
    Rocha JL; Friedman E; Boson W; Moreira A; Figueiredo B; Liberman B; de Lacerda L; Sandrini R; Graf H; Martins S; Puñales MK; De Marco L
    Hum Mutat; 1999; 14(3):233-9. PubMed ID: 10477431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nephrogenic diabetes insipidus].
    Ishikawa SE
    Nihon Rinsho; 2002 Jan; 60 Suppl 1():515-21. PubMed ID: 11838161
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary excretion of aquaporin-2 in patients with diabetes insipidus.
    Kanno K; Sasaki S; Hirata Y; Ishikawa S; Fushimi K; Nakanishi S; Bichet DG; Marumo F
    N Engl J Med; 1995 Jun; 332(23):1540-5. PubMed ID: 7537863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine.
    Deen PM; Verdijk MA; Knoers NV; Wieringa B; Monnens LA; van Os CH; van Oost BA
    Science; 1994 Apr; 264(5155):92-5. PubMed ID: 8140421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans.
    Bankir L; Fernandes S; Bardoux P; Bouby N; Bichet DG
    J Am Soc Nephrol; 2005 Jul; 16(7):1920-8. PubMed ID: 15888562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biology of hereditary diabetes insipidus.
    Fujiwara TM; Bichet DG
    J Am Soc Nephrol; 2005 Oct; 16(10):2836-46. PubMed ID: 16093448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrogenic diabetes insipidus: causes revealed.
    Holtzman EJ; Ausiello DA
    Hosp Pract (Off Ed); 1994 Mar; 29(3):89-93, 97-8, 103-4. PubMed ID: 8132731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nephrogenic diabetes insipidus].
    Evrard A; Lefebvre J; Vantyghem M
    Ann Endocrinol (Paris); 1999 Dec; 60(6):457-64. PubMed ID: 10617799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families.
    Pasel K; Schulz A; Timmermann K; Linnemann K; Hoeltzenbein M; Jääskeläinen J; Grüters A; Filler G; Schöneberg T
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1703-10. PubMed ID: 10770218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
    Devuyst O
    Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.